Clinisys Advances Lab Informatics with Governed AI in CLS v2025.3

TUCSON, Ariz. – July 21, 2026 – Clinisys, a global leader in laboratory informatics, today announced the general availability of Clinisys™ Laboratory Solution (CLS) v2025.3. This major release continues the evolution of its unified, cloud-native platform, introducing significant advancements in governed artificial intelligence, interoperability, and scalable configuration designed to empower scientific and healthcare laboratories worldwide.

The update strengthens CLS as a comprehensive operational system of record, supporting the entire laboratory lifecycle from specimen collection and genomics to biorepository management and scientific research. By embedding practical AI capabilities and deepening platform integrations, Clinisys aims to help laboratories simplify complex operations, gain unprecedented visibility, and scale their workflows with confidence in highly regulated environments.

The Rise of Governed AI in Regulated Labs

Artificial intelligence is no longer a future promise in laboratory settings; with CLS v2025.3, it is an integrated, operational reality. Clinisys is pioneering the use of "governed AI," a framework designed to connect structured laboratory data, standardized workflows, and integrated analytics within a traceable and controlled environment. This approach ensures that AI-driven insights and automation operate with the transparency, compliance, and human oversight required in regulated industries.

Central to this strategy is CLS CARE, a governed AI assistant embedded directly within the platform. Launched in a prior version and enhanced in this release, CLS CARE functions as a conversational agent that provides users with clear, reliable answers grounded exclusively in validated CLS documentation. Laboratory teams can now ask questions in plain language to understand system functionality, interpret release notes, or even get guidance on API capabilities and code generation for integrations. This provides immediate, contextual support, accelerating user adoption and optimizing workflows.

Beyond the assistant, AI is woven into the fabric of core laboratory operations. The platform now applies intelligence to support quality monitoring, instrument coordination, and operational insight. By improving visibility into lab activity and resource utilization, these capabilities help organizations optimize everything from sampling and throughput to resource allocation, delivering measurable improvements in efficiency and cost-effectiveness. This moves AI from a theoretical 'black box' to a transparent, auditable tool that enhances, rather than replaces, expert human judgment.

A Unified Platform Strategy to Simplify Complexity

A persistent challenge for modern laboratories is the fragmentation of data and workflows across disparate systems. Clinisys addresses this head-on with its vision of a unified platform. CLS v2025.3 makes significant strides in realizing this vision by extending its interoperability and breaking down silos between different laboratory disciplines.

The release deepens integration with Clinisys™ Collect, a mobile application that applies CLS ordering logic, specimen identification, and audit controls directly at the point of care. This ensures data integrity and traceability from the very beginning of the specimen lifecycle.

For organizations engaged in both operational testing and scientific research, the new connectivity with the SciNote electronic laboratory notebook (ELN) is a landmark enhancement. This integration connects the structured, process-driven world of the LIMS with the flexible, experimental documentation of the ELN. Researchers can now maintain a continuous, traceable data thread from sample intake through experimental analysis and output, fostering collaboration and eliminating the data gaps that often exist between R&D and production.

Further simplifying external interactions, CLS v2025.3 introduces the Clinisys™ Gateway Module. This modernized client portal, an evolution of the previous LabOnline solution, provides a refreshed, CLS-aligned user experience for test ordering and results access. Crucially, it preserves familiar workflows, enabling a smooth transition for clients without the need for extensive retraining or operational disruption.

Driving Performance, Scalability, and Compliance

Beyond new features, CLS v2025.3 delivers foundational improvements designed to boost performance and enable scalable growth. The release enhances the platform's cloud-native architecture, offering a robust SaaS model that reduces infrastructure and maintenance complexity for laboratories. This approach not only improves performance and operational consistency but also grants clients greater flexibility in managing upgrade schedules while maintaining stringent data security and controlled configurations.

A modernized, scalable approach to test configuration allows laboratories to design, adapt, and maintain complex workflows with greater speed, control, and consistency. This is particularly valuable for large, multi-site networks that need to standardize processes while still accommodating specialized and regulated testing requirements.

The integrated Clinisys™ Analytics Module also receives a significant upgrade, with AI-assisted analytics that provide role-aligned visibility into operational performance and quality metrics. Users can surface patterns and insights within a controlled, explainable framework, enabling timely, data-driven decisions that support audit readiness and continuous improvement without relying on separate, disconnected analytics tools.

“With CLS v2025.3, we continue to advance our vision of a unified laboratory platform that connects data, workflows, and insight,” said Anthony Ventress, Chief Product Officer at Clinisys. “This release reflects our commitment to helping laboratories simplify adoption, strengthen interoperability, and scale confidently—while maintaining the governance and assurance required in regulated settings.”

Building on a Foundation of Global Expertise

With over 40 years of experience, Clinisys has established itself as a trusted partner to more than 7,000 laboratories across 42 countries. Its solutions generate millions of laboratory results and data insights daily, supporting healthcare, life sciences, and public health organizations. The company’s customer-centric approach, evidenced by recent successful deployments like the digital pathology transformation at Stockport NHS Foundation Trust, ensures its technology evolves to meet the real-world needs of laboratory professionals.

This latest release is more than an incremental update; it represents a significant step forward in the company's mission to future-proof laboratory informatics. By delivering a single, intelligent platform that is both powerful and compliant, Clinisys is equipping laboratories with the tools they need to navigate an increasingly complex landscape and contribute to a healthier and safer world.